A real public health problem due to the number of people who have it, type 2 diabetes is generally managed with changes in lifestyle and diet, and insulin for better glycemic control.
In a new scientific study published in the Journal of Clinical Endocrinology & Metabolism from the Endocrine Society, researchers are reporting another class of drugs that may help with blood sugar control. These are antacids, more specifically the class of proton pump inhibitors (PPIs).
“Our research has shown that the prescription of antacids in addition to standard care was superior to standard treatment in reducing hemoglobin A1c levels (HbA1c, a marker for assessing glycemic balance over a long period, editor’s note) and blood sugar levels. fasting in people with diabetes”, Commented Dr. Carol Chiung-Hui Peng, first author of the study and researcher at the University of Maryland in Baltimore (United States).
The analysis included seven studies (342 participants) to investigate the effect of PPIs on glycemic control, and 5 studies (244,439 participants) to assess the risk of developing diabetes. The researchers found thate antacids can reduce HbA1c levels by 0.36% in people with diabetes, and lower fasting blood sugar by 10 mg / dl. On the other hand, for people without diabetes, antacids would have no effect on reducing the risk of developing diabetes.
“People with diabetes should be aware that these commonly used antacid drugs can improve their blood sugar control, and healthcare professionals should consider this blood sugar lowering effect when prescribing these drugs to their patients.”, Concluded in a communicated Dr. Kashif Munir, Professor in the Division of Endocrinology, Diabetes and Nutrition, University of Maryland School of Medicine.
In other words, a person with diabetes taking both insulin to regulate their blood sugar, and antacids for another health problem, may experience a drop in their blood sugar more than expected.